周二晚些时候,Diffusion宣布股东批准了合并。该公司还计划在上市前进行1比1.5的反向拆股,以符合纳斯达克的上市要求。合并后公司的股票原定于8月17日开始交易。
美股滚雪球2023-08-16 09:53
$Diffusion制药(DFFN)$ 股东投票通过了该公司与EIP Pharma的合并。预计将于8月16日结束。该公司还表示,股东们同意1比1.5的反向拆股方案。新公司将被命名为CervoMed,从8月17日开始,股票代码为“CRVO”
$贝达药业(SZ300558)$ $通策医疗(SH600763)$查看全文
美股滚雪球2023-03-31 09:57
$Diffusion制药(DFFN)$ 宣布与私人持有的EIP Pharma进行全股票合并。合并后的公司预计将更名为CervoMed,并以新的股票代码CRVO进行交易。该公司将专注于推进EIP Pharma的主要药物产品neflamabimod,该药物正在开发中,用于治疗路易体痴呆症(DLB)。
合并后的公司将继续在纳斯达克资本市场以新...查看全文
$Diffusion制药(DFFN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-10 AccNo: 0001437749-18-015223 Size: 3 MB 网页链接
$Diffusion制药(DFFN)$ 8-K - Current report Filed: 2018-06-15 AccNo: 0001437749-18-011908 Size: 38 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Diffusion制药(DFFN)$ 8-K - Current report Filed: 2018-05-10 AccNo: 0001437749-18-009449 Size: 140 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Diffusion制药(DFFN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-10 AccNo: 0001437749-18-009433 Size: 2 MB 网页链接
$Diffusion制药(DFFN)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-04-30 AccNo: 0001437749-18-008133 Size: 567 KB 网页链接
$Diffusion制药(DFFN)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-30 AccNo: 0001437749-18-008132 Size: 1 MB 网页链接
$Diffusion制药(DFFN)$ PRE 14A - Other preliminary proxy statements Filed: 2018-04-20 AccNo: 0001437749-18-007347 Size: 1 MB 网页链接
$Diffusion制药(DFFN)$ 8-K - Current report Filed: 2018-04-03 AccNo: 0001437749-18-006155 Size: 134 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Diffusion制药(DFFN)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-04-02 AccNo: 0001437749-18-006050 Size: 7 MB 网页链接
$Diffusion制药(DFFN)$ 8-K - Current report Filed: 2018-03-19 AccNo: 0001437749-18-004965 Size: 55 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接